INTRODUCTION OnabotulinumtoxinA (ONA; Botox, Allergan, Irvine, CA) was discovered for cosmetic use in the mid-1980s for which it was FDA approved in April 2002. AbobotulinumtoxinA (ABO; Dysport, Valeant Pharmaceuticals International, Inc, Montreal, Quebec) was FDA approved in April 2009 for therapeutic and esthetic uses. The most recent studies make a comparison between the two formulations; ho...

Abstract Aims Botulinum Toxin A (BTA) is widely used in complex abdominal wall reconstruction (CAWR). It temporarily paralyses the oblique muscles allowing medialisation of rectus sheath and decreases tension on closure. This analysis presents use BTA management ‘open abdomen’ (OA). Methods Retrospective series patients with OA where was conjunction AbtheraTM negative pressure wound therapy (NP...